Please find attached herewith report for the period from 01.01.2026 to 06.01.2026 pertaining to re-lodgment of transfer of physical shares

Titan Biotech Ltd has submitted a routine compliance report covering the period from January 1 to January 6, 2026, regarding re-lodged physical share transfer requests under SEBI's special window facility. During this 6-day period, the company received 2 transfer requests, of which 1 was approved and 1 was rejected, with an average processing time of 20 days. One of the processed transfers required a public notice, which was published in the newspaper on January 30, 2026. The report was prepared by the company's Registrar and Share Transfer Agent, Beetal Financial & Computer Services (P) Ltd, and filed pursuant to SEBI Circular dated July 2, 2025. This is a standard regulatory disclosure required under the special window framework allowing re-lodgement of physical share transfers that were previously disallowed due to documentation issues.